Skip To Main Content
Jessica Brown on Muck Rack

Jessica Brown

As seen in: MSN, MSN Canada, Daily Star (UK), News.com.au, MDPI, Bored Panda, Irish Independent, The Herald Sun, Cell Press, Montreal Gazette and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jessica

Contact Jessica, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Refinancing surge expected across SA following RBA decision

|
By Jessica Brown, Matt Bell
| RealEstate
Open in Who Shared Issue with article?

Assessment Tools to Examine Illness Understanding in Patients with Advanced Cancer: A Systematic Review of Randomized Clinical Trials

|
By Ashlyn Y Tu, Kate Krause, Jessica Brown, David Y. Hui
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Clinical trial shows 'dramatic and rapid' progress against aggressive brain cancer

|
By Jessica Brown, Shaun Ganley Verified
| KMBC-TV (Kansas City, MO) Verified
A new treatment for a lethal brain cancer known as glioblastoma has shown remarkable early results, new research from the Mass General Cancer Center in Boston shows. The New England Journal of Medicine published results of a phase 1 clinical trial of a novel CAR-T used in patients with recurring glioblastoma, which showed dramatic and rapid tumor reduction.
Open in Who Shared View Duplicates (26) Issue with article?
See all 193 licensed articles (214 Total)